Portfolio company
StratifAI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
ViewsML
This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.
Panakeia
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
Ataraxis AI
This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.
Waiv
This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.
